Oct 14 (Reuters) - Catalent ( CTLT ) said on Monday it
had agreed to sell its oral solids development and small-scale
manufacturing facility in Somerset, New Jersey to private
contract drug manufacturer Ardena.
(Reporting by Bhanvi Satija in Bengaluru; Editing by Anil
D'Silva)